Lecture Series on Cancer Breakthroughs:PERSONALIZED CANCERPREVENTION
Lecture starts in
Friday 18 September 2026
Prof. Timothy R. Rebbeck
Harvard T.H. Chan School of Public Health – Dana-Farber Cancer Institute
Paris, in person and online, 5pm CEST
An annual lecture series shaping the future of clinical oncology
We are delighted to invite you to the inaugural Gustave Roussy–Lancet Lecture Series on Cancer Breakthroughs. This annual series of clinical oncology lectures will bring together leading oncologists from around the world to present and discuss emerging concepts shaping the future of cancer care.
This inaugural lecture will be delivered by Professor Timothy R. Rebbeck, an internationally recognised leader in cancer epidemiology and prevention, and will focus on personalised cancer prevention. Professor Rebbeck will explore the full potential of precision cancer prevention, including how risk-stratified approaches can help identify the right person, time, and intervention to prevent cancer.
Open to the public, this Lecture Series will be of particular interest to clinicians, researchers, healthcare professionals, students, and others working in the field of oncology. The lecture will be followed by a live panel discussion, an audience Q&A session, and an in-person networking drinks reception.
18 September 2026
Lecture, Panel Discussion, Q&A, and Networking
Hybrid Format
In person + Online
Paris
Gustave Roussy Campus
Featured Speaker
Prof. Timothy R. Rebbeck
Vincent L. Gregory Professor of Cancer Prevention, Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute
An internationally recognized leader in cancer epidemiology and prevention, Prof. Rebbeck's research focuses on the genetic, genomic, and environmental determinants of cancer risk, and on translating these insights into personalized prevention strategies for diverse populations worldwide.
His keynote will explore how precision medicine, polygenic risk scores, and population-level interventions are reshaping how we prevent — not only treat — cancer.
Programme
- 16:30CEST
Registration Opens
Welcome desk and check-in.
- 17:00CEST
Welcome, Opening Remarks & Introduction
Suzette Delaloge (Gustave Roussy) & Vania Wisdom (The Lancet).
- 17:10CEST
Keynote Lecture: Personalized Cancer Prevention
Prof. Timothy R. Rebbeck (Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute).
- 17:55CEST
Panel Discussion
Tim Rebbeck (Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute); Suzette Delaloge (Gustave Roussy); Judith Balmaña (Vall d'Hebron, Barcelona). Chair: Dr Richard Horton, Editor-in-Chief (The Lancet).
- 18:40CEST
Audience Q&A
Open questions from in-person and online audience.
- 19:00CEST
Closing Remarks
Vania Wisdom (The Lancet) & Fabrice Barlesi (CEO, Gustave Roussy).
- 19:05CEST
Networking Drinks
Networking with speakers and attendees.
All times CEST. Programme is indicative and may be subject to change.
Hosted by Gustave Roussy, in partnership with The Lancet
A scientific collaboration led by Gustave Roussy Cancer Campus Grand Paris with The Lancet, advancing the global conversation on oncology.
Venue
Venue
The Hive — Paris-Saclay Cancer Cluster
Campus Grand Parc, Villejuif, 94800, France
City
Villejuif, Greater Paris
Just 20 minutes from central Paris via metro lines 14 and 15.
Hybrid
Online Access
Streaming details and access link will be sent by email upon registration.
